|Articles|June 1, 2006
- Special Issues-07-01-2006
- Volume 0
- Issue 0
Validation in Biotechnology and Well-Characterized Biopharmaceutical Products
This article describes the current situation in FDA-regulated areas, as well as characterization of these products. Finally,the author discusses the various stages of early- and late-phase product developments.
Advertisement
Articles in this issue
about 20 years ago
Analytical Instrument Qualificationabout 20 years ago
GMP and Phase I Clinical Trials: Streamlining the Critical Path?about 20 years ago
Team Effortabout 20 years ago
Rated PG: Pharmaceutical Guidance Suggestedabout 20 years ago
European Clinical Trial Regulations Undergo a Slow Revolutionabout 20 years ago
Moving Biotech Products from CBER to CDER: A Work in Progressabout 20 years ago
FDA Video Interview Conducted by Jill Wechsler, Washington Bureau Chiefabout 20 years ago
New Climateabout 20 years ago
2006: A Regulatory OdysseyAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on LCGC International
1
Industry Roundup: Shimadzu Unveils New High-End UHPLC System Aimed at Reducing Laboratory Downtime
2
VASE-GC-MS Detects Personal Care Products in Fish
3
Industry Roundup: Gerstel Showcased New Twister Phases and Automated Liner Exchange Technology at EPRW 2026 in Rotterdam
4
LC-MS/MS Compares Hair Hormone Sampling Methods
5